Concerns and beliefs about medicines and inappropriate medications: An Internet-based survey on risk factors for self-reported adverse drug events among older adults

The American Journal of Geriatric Pharmacotherapy
Olayinka O Shiyanbola, Karen B Farris

Abstract

Adverse drug events (ADEs), which can be especially problematic in older adults, often can be prevented by detecting potential risk factors. Sociopsychological factors such as concerns and beliefs about medicines (patients' anxieties about the harmful effects of prescribed medications) may also be risk factors related to self-reported ADEs, even when considering clinical variables such as receiving an inappropriate medication. This study was designed to quantify the use of inappropriate medications among older adult outpatients and to determine whether an association exists between the use of inappropriate medications, concerns and beliefs about medicines, and self-reported ADEs. This cross-sectional, Internet-based survey of Medicare beneficiaries was conducted in 2007. Harris Interactive, a New York-based marketing research firm, invited participants from their online panel who were >or=65 years of age, residents of the United States, and enrolled in the Medicare health plan to participate in the survey. The updated Beers criteria and a modified version of the Assessing Care of Vulnerable Elders quality indicators were used to determine the appropriateness of medications. Respondents' concerns about their medicines were asses...Continue Reading

References

Oct 15, 1992·Annals of Internal Medicine·M H BeersJ C Beck
Jul 5, 1995·JAMA : the Journal of the American Medical Association·D W BatesR Hallisey
Sep 1, 1993·Comprehensive Psychiatry·J KauhanenJ T Salonen
Aug 1, 1997·Journal of the American Geriatrics Society·J T HanlonI K Lewis
Oct 24, 1997·Archives of Internal Medicine·J L BootmanE Cox
Aug 5, 2000·The Annals of Pharmacotherapy·R R Aparasu, J R Mort
Oct 26, 2000·European Journal of Epidemiology·K H LadwigG Dammann
Apr 12, 2001·Journal of the American Pharmaceutical Association : APhA·F R Ernst, A J Grizzle
Sep 15, 2001·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·J T HanlonK E Schmader
Dec 11, 2002·Social Science & Medicine·Daniel S BailisJudith G Chipperfield
Dec 31, 2002·The Annals of Pharmacotherapy·Hélène PeyriereSylvie Hansel
Mar 8, 2003·JAMA : the Journal of the American Medical Association·Jerry H GurwitzDavid W Bates
Apr 18, 2003·The New England Journal of Medicine·Tejal K GandhiDavid W Bates
Feb 11, 2004·Archives of Internal Medicine·Margie Rauch Goulding
May 6, 2004·Annals of Internal Medicine·Takahiro HigashiNeil S Wenger
Jul 24, 2004·Journal of the American Geriatrics Society·Terry S FieldDavid W Bates
Aug 11, 2004·Archives of Internal Medicine·Lesley H CurtisKevin A Schulman
Oct 28, 2004·Journal of the American Geriatrics Society·Alex Z FuDale B Christensen
Nov 24, 2004·The American Journal of Geriatric Pharmacotherapy·Rajender R Aparasu, Jane R Mort
Jan 26, 2005·Archives of Internal Medicine·Saul N WeingartDavid W Bates
Apr 13, 2005·Archives of Internal Medicine·Josh F PetersonDavid W Bates
May 18, 2005·The Annals of Pharmacotherapy·R Scott EvansMatthew H Samore
May 25, 2005·European Journal of Clinical Pharmacology·Graziano OnderRoberto Bernabei
Jun 2, 2005·The Annals of Pharmacotherapy·Ghada K Al-Tajir, William N Kelly
Nov 1, 2005·The American Journal of Geriatric Pharmacotherapy·Susan J BlalockJoanne M Jordan
Sep 21, 2006·The Annals of Pharmacotherapy·Hemant M Phatak, Joseph Thomas
Sep 27, 2006·Medical Care·William H ShrankElizabeth A McGlynn
Jan 20, 2007·Journal of the American Geriatrics Society·Elizabeth ChrischillesRobert Wallace
May 12, 2007·Journal of the American Geriatrics Society·Anne SpinewinePaul M Tulkens
Oct 4, 2007·Journal of the American Geriatrics Society·Neil S Wenger, Roy T Young
Nov 22, 2007·The Annals of Pharmacotherapy·Olayinka OladimejiWilliam R Doucette
Jan 1, 2008·Research in Nursing & Health·Donna M FickJennifer L Waller
Apr 29, 2008·Journal of Hospital Medicine : an Official Publication of the Society of Hospital Medicine·Michael B RothbergPeter K Lindenauer
Jun 10, 2009·Journal of the American Geriatrics Society·Elizabeth A ChrischillesRobert B Wallace
Sep 8, 2009·Research in Social & Administrative Pharmacy : RSAP·Olayinka OladimejiWilliam R Doucette

❮ Previous
Next ❯

Citations

Dec 19, 2013·PloS One·Francesco NapolitanoUNKNOWN Collaborative Working Group
Sep 17, 2013·Journal of Women's Health·Elizabeth A StewartBijan J Borah
Jan 1, 2014·British Journal of Clinical Pharmacology·Katja M HakkarainenStaffan Hägg
Feb 17, 2015·Journal of Clinical Pharmacy and Therapeutics·A P A L SantosD P Lyra
Mar 19, 2014·Journal of the American Geriatrics Society·Meegan L RemillardJennifer Tjia
Nov 9, 2016·Scandinavian Journal of Primary Health Care·Sonja KallioMarja Airaksinen
Jun 28, 2014·Expert Review of Pharmacoeconomics & Outcomes Research·Charles EllisBruce Ovbiagele
Jun 3, 2021·Pharmacy : Journal of Pharmacy, Education and Practice·Hoan Linh Banh, Andrew J Cave

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The Annals of Pharmacotherapy
Olayinka OladimejiWilliam R Doucette
The New England Journal of Medicine
Tejal K GandhiDavid W Bates
© 2021 Meta ULC. All rights reserved